Your browser doesn't support javascript.
Chronic Cavitary Pulmonary Histoplasmosis in an Immunocompetent Patient.
Albandak, Maram; Azar, Jehad; Ayyad, Mohammed; Salah, Qais; Toqan, Anas; Giacaman, Narmeen; Marzouqa, Nizar; Al-Tawil, Mohammed; Wishah, Bisan; Barabrah, Anas.
  • Albandak M; Internal Medicine, Al-Quds University, Jerusalem, PSE.
  • Azar J; Respiratory Institute, Cleveland Clinic, Cleveland, USA.
  • Ayyad M; Internal Medicine, Al-Quds University, Jerusalem, PSE.
  • Salah Q; Internal Medicine, Al-Quds University, Jerusalem, PSE.
  • Toqan A; Internal Medicine, Al-Quds University, Jerusalem, PSE.
  • Giacaman N; Internal Medicine, Al-Quds University, Jerusalem, PSE.
  • Marzouqa N; Internal Medicine, Al-Quds University, Jerusalem, PSE.
  • Al-Tawil M; Internal Medicine, Al-Quds University, Jerusalem, PSE.
  • Wishah B; Epidemiology and Public Health, Western Sydney University, Sydney, AUS.
  • Barabrah A; Internal Medicine, Al-Quds University, Jerusalem, PSE.
Cureus ; 15(4): e37095, 2023 Apr.
Article in English | MEDLINE | ID: covidwho-20232038
ABSTRACT
Histoplasma capsulatum is a fungal organism that causes systemic histoplasmosis. It is commonly asymptomatic in healthy immunocompetent individuals. The clinical symptoms of chronic cavitary histoplasmosis are typically seen in the immunodeficient population, particularly in smokers with pre-existing structural lung disease. We report a case of chronic cavitary histoplasmosis in an immunocompetent patient from an endemic area without pre-existing structural lung pathology. She presented complaining of right hypochondrial pain and had no history of respiratory symptoms nor history suggestive of immunosuppression, tuberculosis, or recent travel. CT scan revealed a cavitary lung lesion and a hilar mediastinal mass. Biopsies obtained by bronchoscopy revealed signs of necrosis, granulomas, and the presence of fungal organisms consistent with histoplasmosis. Histoplasma antibodies by complement fixation for yeast antibodies test were positive establishing the diagnosis of chronic cavitary pulmonary histoplasmosis (CCPH). She was then started on itraconazole with good tolerance. On follow-up three months later, a chest CT done along with measurement of inflammatory markers and liver enzymes demonstrated complete clinical recovery. This case emphasizes the importance of expanding our current understanding of the clinical presentation and manifestations of histoplasmosis beyond the conventional assumption that severe disease only affects immunocompromised individuals.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Cohort study / Prognostic study Language: English Journal: Cureus Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Cohort study / Prognostic study Language: English Journal: Cureus Year: 2023 Document Type: Article